Clinical trials
Phase 1/2 Neoplasms by Site trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 2 |
| 2011 | 2 |
| 2013 | 1 |
| 2017 | 4 |
| 2018 | 2 |
| 2019 | 5 |
| 2022 | 1 |
| 2023 | 4 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 9 |
| Completed | 8 |
| Active, not recruiting | 3 |
| Terminated | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 3 |
| Bristol-Myers Squibb | 2 |
| Revolution Medicines, Inc. | 2 |
| Advanced Accelerator Applications | 1 |
| Atara Biotherapeutics | 1 |
| BBB-Therapeutics B.V. | 1 |
| BeiGene USA, Inc. | 1 |
| Cerenome | 1 |
| Ensem Therapeutics | 1 |
| Hoffmann-La Roche | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms by Site | 23 |
| Neoplasms | 21 |
| Head and Neck Neoplasms | 9 |
| Lung Neoplasms | 9 |
| Carcinoma, Non-Small-Cell Lung | 8 |
| Central Nervous System Neoplasms | 7 |
| Gastrointestinal Neoplasms | 7 |
| Breast Neoplasms | 6 |
| Bronchial Neoplasms | 6 |
| Carcinoma | 6 |
Trials
Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.